Disruption of autophagy by increased 5-HT alters gut microbiota and enhances susceptibility to experimental colitis and Crohn’s disease

Autor: Yun Han Kwon, Gregory R. Steinberg, Sabah Haq, Usha Chauhan, John H. Brumell, Francine Côté, Jensine Grondin, John Marshall, Huaqing Wang, Waliul I. Khan, Michael G. Surette, Suhrid Banskota, Irfan I. Khan, Dana J. Philpott
Přispěvatelé: Centre National de la Recherche Scientifique (CNRS)
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Zdroj: Science Advances
Science Advances, American Association for the Advancement of Science (AAAS), 2021, 7 (45), ⟨10.1126/sciadv.abi6442⟩
ISSN: 2375-2548
DOI: 10.1126/sciadv.abi6442⟩
Popis: Description
Elevated gut serotonin inhibits autophagy via mTOR promoting a disrupted microbiota and enhanced susceptibility to colitis.
Autophagy, an essential intracellular recycling process, is linked to the pathogenesis of various diseases including Crohn’s disease (CD). Factors that lead to the development of impaired autophagy during intestinal inflammation remain largely unexplored. Here, we report the impact of the interaction between serotonin [5-hydroxytryptamine;(5-HT)] and autophagy in colitis in mouse and human studies. In mice, increased gut 5-HT inhibited autophagy and led to enhanced colitis susceptibility. Reciprocally, mice with reduced 5-HT exhibited up-regulated autophagy via the mammalian target of rapamycin pathway, which resulted in significantly decreased colitis. Deletion of autophagy gene, Atg7, in an epithelial-specific manner, in concert with reduced 5-HT, promoted the development of a colitogenic microbiota and abolished the protective effects conferred by reduced 5-HT. Notably, in control and patient peripheral blood mononuclear cells, we uncovered that 5-HT treatment inhibited autophagy. Our findings suggest 5-HT as a previously unidentified therapeutic target in intestinal inflammatory disorders such as CD that exhibits dysregulated autophagy.
Databáze: OpenAIRE